Seeing Is Believing
PTCT is currently covered by 15 analysts with an average price target of $43.89. This is a potential upside of $10.27 (30.55%) from yesterday's end of day stock price of $33.62.
PTC Therapeutics's activity chart (see below) currently has 122 price targets and 187 ratings on display. The stock rating distribution of PTCT is 42.65% BUY, 41.18% HOLD and 16.18% SELL.
Analysts average stock forecasts to be materialized ratio is 47.35% with an average time for these price targets to be met of 153.08 days.
Highest price target for PTCT is $56, Lowest price target is $17, average price target is $43.89.
Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 29-Apr-2024. First documented stock forecast 14-Feb-2014.
Currently out of the existing stock ratings of PTCT, 29 are a BUY (42.65%), 28 are a HOLD (41.18%), 11 are a SELL (16.18%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
30
$-4.16 (-12.18%)
28
3 days ago
5/7 (71.43%)
$1.43 (5.01%)
58
Buy
45
$10.84 (31.73%)
45
20 days ago
0/9 (0%)
$18.58 (70.33%)
Hold
30
$-4.16 (-12.18%)
32
2 months 1 days ago
7/7 (100%)
$-1.95 (-6.10%)
76
Hold
28
$-6.16 (-18.03%)
22
2 months 1 days ago
18/22 (81.82%)
$-3.95 (-12.36%)
116
Sell
18
$-16.16 (-47.31%)
22
4 months 14 days ago
3/4 (75%)
$-9.52 (-34.59%)
137
What is PTCT (PTC Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?
Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?
Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?